Meeting
2012 ASCO Annual Meeting
Response of chemoradiation therapy after induction chemotherapy failure in locally advanced head and neck squamous cell carcinoma (LA-HNSCC).
Authors
Yoojoo Lim
Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea
Yoojoo Lim , Bhumsuk Keam , Youngil Koh , Kyung-Hun Lee , Tae Min Kim , Se-Hoon Lee , Jeong-Hun Hah , Tack-Kyun Kwon , Dong-Wan Kim , Hong-Gyun Wu , Myung-Whun Sung , Dae Seog Heo , Kwang Hyun Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Head and Neck Cancer
Citation
J Clin Oncol 30, 2012 (suppl; abstr 5552)
DOI
10.1200/jco.2012.30.15_suppl.5552
Abstract #
5552
Poster Bd #
23D
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
A randomized, multicenter, open phase II study of cetuximab with docetaxel, cisplatin as induction chemotherapy in unresectable, locally advanced head and neck squamous cell carcinoma (LA-HNSCC).
First Author: Youngil Koh
Poster
2019 ASCO Annual Meeting
Induction chemotherapy with docetaxel, cisplatin and cetuximab versus docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced or inoperable squamous cell carcinoma of the head and neck: Promising results of a randomized phase II AGMT-trial.
First Author: Felix Keil
Poster
2019 ASCO Annual Meeting
Randomized phase II study with or without induction chemotherapy combined with accelerated high dose radiotherapy and cetuximab in locally advanced unresectable HPV positive squamous cell carcinoma of the head and neck.
First Author: Signe Friesland
Poster
2014 ASCO Annual Meeting
Randomized phase II trial of weekly paclitaxel, carboplatin, cetuximab (PCC) versus cetuximab, docetaxel, cisplatin, and fluorouracil (C-TPF) in previously untreated patients with locally advanced head and neck squamous cell carcinoma.
First Author: Erminia Massarelli